from the British Journal of Dermatology found that those who were taking statin
drugs had an increased risk for developing herpes zoster, which can cause
severe ongoing pain. Even patients whose
last statin exposure was up to 36 months prior were at risk.The authors recommended widespread use of the
zoster vaccine.However, the vaccine is
not totally effective and is expensive.Using alternative treatments for hyperlipidemia is another reasonable
See British Journal of Dermatology 2017; 175: 1137-1138.
for Disease Control reported that the rate of injuries from falls rose 39% from
2007 to 2013.The rate increased 76% for
people 75 y.o. plus.Brain injuries, hip
fractures, and death are the most devastating results.27,000Americans die from falls each year.Decreased vision, dizziness, and unsteadiness from various chronic
illness all contribute.Much can be done
by having your vision checked yearly and learning exercises that strengthen
your legs and improve balance.A
vibration plate called Vibabody costing about $1500 can be very helpful.Additional railings in the house can reduce
Rogers’s book of that title strikes home.All of us carry significant loads of organic toxins, over and above the
toxic minerals that we hear so much about.Recent urine tests looking for as many as 168 organic toxins have been
developed by prominent holistic labs such as Great Plains Laboratory in Kansas
and Doctor’s Data in Chicago.If you are
found to have high levels of toxins, such measures as milk thistle,
anti-oxidants, saunas, massage, exercise, and foot baths can detoxify.Hopefully, that will help you feel better,
avoid disease, and live longer.
at Massachusetts General Hospital are studying whether it is helpful to add
disease-altering drugs such as those used to treat rheumatoid arthritis to
antibiotics first line to treat Lyme disease.Side effects are of some concern.A much safer and less expensive way to treat the secondary autoimmune
response of Lyme is low-dose immunotherapy (LDI).
I have had
reports of TTFD and niacinamide giving pain relief from two different
physicians prominent in the field of nutritional medicine, Derrick Lonsdale and
Jonathan Wright.Both of them emphasize
that if you take single B-vitamins over time you can create an imbalance of
other B-vitamins.It is best to take
high potency B1, B6, and B12 concurrently or perhaps separately, even 3 or 4 a
day to accomplish significant pain relief from osteoarthritis or muscle
pain.Rare cases of B6 given
independently in doses greater than 200 mg a day have resulted in toxicity.
See Jonathan Wright’ Green Medicine, Sept. 2016 and Derrick
Lonsdale, personal communication, November, 2016.
of joint swelling and pain might be as important as sophisticated testing to
distinguish the type of arthritis you have.Multiple joints are usually involved with rheumatoid arthritis,
osteoarthritis, and autoimmune problems.Autoimmune and rheumatoid arthritis are more likely to be symmetrical
and involve the upper body. Lower body involvement points more toward osteoarthritis
and gout.Of course it is also possible
to have more than one form of these common diseases.Your diagnosis is important because the
treatment might be different for different conditions.
The risk of
complications from colonoscopies might outweigh the potential benefits after
the age of 75, unless you have a history of polyps previously treated.Mammograms over the age of 70 and sometimes
earlier than that can lead to overtreatment.Thermographies might be better as a preventive test.With no previous history of precancerous
lesions, pap smears can be discontinued at age 65.PSA’s have no benefit after the age of 75 and
are optional for men before that.Bone
density tests are recommended every five years, beginning at age 65 for women
and 70 for men.One ultrasound per
lifetime to screen for abdominal aneurysm is recommended.I would add CardioRisk tests for arterial
plaque, a questionnaire for the risk of falls, and periodic blood tests for
vitamin D, CRP sensitive, glucose, Lp(a), and other lipids.
See AARP Magazine, February/March issue, 2017, p. 24-25.